Skip to main content

Miromatrix Medical Inc.

MIRODelisted Dec 13, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001527096

Miromatrix Medical Inc. was delisted on Dec 13, 2023; its insiders filed their last Form 4 on Dec 13, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $8.78M in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Miromatrix Medical Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of MIRO: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders1922+3
Shares3.16M3.08M−73.1K (−2.3%)
Value$22.0M$14.5M−$7.51M (−34.2%)

New holders (6)

Institutions that held Miromatrix Medical Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to MIRO in Q4 2021
InstitutionSharesValue% of portfolio
Vanguard Group Inc154,376$724.0K0.00%
Cambridge Investment Research Advisors, Inc.36,400$171.0K0.00%
Renaissance Technologies LLC15,821$74.0K0.00%
Citadel Advisors LLC16,013$74.0K0.00%
US Bancorp10,000$47.0K0.00%
Sweet Financial Partners, LLC10,000$47.0K0.02%

Sold out (3)

Institutions that held Miromatrix Medical Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of MIRO in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
AWM Investment Company, Inc.116,688$812.0K
Manatuck Hill Partners, LLC83,042$578.0K
Millennium Management LLC44,315$308.0K